no image available Dickens & Co. "Breaking New Ground: SGN75's Promising Advance in the Battle Against Blood Cancers and Kidney Cancer" "A Phase I dosescalation study brings hope to patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma and metastatic renal cell carcinoma" Price: 25.00€